ReviewFrontiers in immunology2023

Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations.

Jeremy D Rubinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.